Anhui Anke Biotechnology (Group) Co., Ltd. (300009.SZ) SHZ
Currency In CNY
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In CNY
| Market Cap | 15.99B |
| Enterprise Value | 15.77B |
| P/E Ratio | 18.42 |
| PEG Ratio | -7.92 |
| Price/Sales Ratio | 5.01 |
| Price/Book Ratio | 2.7 |
| Enterprise/Revenue | 4.96 |
| Enterprise/EBITDA | 14.69 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
| Profit Margin | 0.27 |
| Operating Margin | 0.3 |
| Return On Assets | 0.12 |
| Return On Equity | 0.16 |
| Revenue | 2.65B |
| Revenue/Share | 1.53 |
| Gross Profit | 2B |
| EBITDA | 959.03M |
| Net Income | 735.19M |
| Diluted EPS | 0.44 |
| Total Cash | 1.66B |
| Total Cash/Share | 0.99 |
| Total Debt | 57.43M |
| Total Debt/Equity | 0.01 |
| Current Ratio | 4.3 |
| Book Value Per Share | 2.94 |
| 52-Week Change | -7.14 |
| 52-Week High | 13.06 |
| 52-Week Low | 7.35 |
| Moving Average 50 Days | 8.68 |
| Moving Average 200 Days | 9.69 |
| Average Volume | 18.02M |
| Shares Outstanding | 1.67B |
| % Held by Institutions | N/A |
| Trailing Annual Dividend Rate | 0.25 |
| Trailing Annual Dividend Yield | 3.26 |
| Payout Ratio | 0.37 |
| Last Split Factor | 6:5 |
| Last Split Date | May 14, 2021 |